Cargando…

In silico molecular docking: Evaluation of coumarin based derivatives against SARS-CoV-2

BACKGROUND: The unique anthropological coronavirus which has been titled as SARS-CoV-2 was originally arisen in late 2019 in Wuhan, China affecting respiratory infection named as COVID-19. Coronavirus is disturbing human life in an exceptional method and has converted a public health global crisis....

Descripción completa

Detalles Bibliográficos
Autores principales: Chidambaram, Sathish Kumar, Ali, Daoud, Alarifi, Saud, Radhakrishnan, Surendrakumar, Akbar, Idhayadhulla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505582/
https://www.ncbi.nlm.nih.gov/pubmed/33008777
http://dx.doi.org/10.1016/j.jiph.2020.09.002
_version_ 1783584842978426880
author Chidambaram, Sathish Kumar
Ali, Daoud
Alarifi, Saud
Radhakrishnan, Surendrakumar
Akbar, Idhayadhulla
author_facet Chidambaram, Sathish Kumar
Ali, Daoud
Alarifi, Saud
Radhakrishnan, Surendrakumar
Akbar, Idhayadhulla
author_sort Chidambaram, Sathish Kumar
collection PubMed
description BACKGROUND: The unique anthropological coronavirus which has been titled as SARS-CoV-2 was originally arisen in late 2019 in Wuhan, China affecting respiratory infection named as COVID-19. Coronavirus is disturbing human life in an exceptional method and has converted a public health global crisis. Natural products are ahead consideration due to the huge beneficial window and effective anti-inflammatory, immunomodulatory, antioxidant and antiviral possessions. Consequently, the present study was intended to display inhibition ability of natural products coumarins and their analogues against SARS coronavirus. METHODS: The present study, aims to forecast theoretical assembly for the protease of COVID-19 and to discover advance whether this protein may assist as a target for protease inhibitors such as psoralen, bergapten, imperatorin, heraclenin, heraclenol, saxalin, oxepeucedanin, angelicin, toddacoumaquinone, and aesculetin. The docking score of these natural coumarin analogues compared with standard Hydroxychloroquine. Whereas the 3D assembly of main protease of SARS coronavirus was forecast with SWISS MODEL web server, and molecular interaction studies amongst target protein and ligands were done with AutoDock Vina software. RESULTS: The study more exposed that all the inhibitors acquired with negative dock energy against the target protein. Molecular docking investigation displayed that natural coumarin analogue toddacoumaquinone displayed a remarkable inhibition ability with the binding energy of −7.8 kcal/mol than other compounds against main protease of SARS coronavirus in intricate with α-ketoamide (PDB ID: 5N5O). The synthetic coumarin analogue (1 m) also displayed the comparable inhibition ability with a binding energy of −7.1 kcal/mol against main protease of SARS coronavirus in intricate with α-ketoamide. Keeping the overhead results of ADME and toxicity, all tested compounds were recognized as drug-like nature, passing Lipinski’s “Rule of 5” with 0 violation except α-ketoamide passes Lipinski’s “Rule of 5” with 1 violation MW > 500. The projected constraints are within the assortment of recognized values. CONCLUSIONS: Based upon the results of the manifold sequence alliance, natural and synthetic coumarin binding sites were preserved. The present in silico examination thus, delivers structural awareness about the protease of COVID-19 and molecular relations with some of the recognised protease inhibitors.
format Online
Article
Text
id pubmed-7505582
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.
record_format MEDLINE/PubMed
spelling pubmed-75055822020-09-23 In silico molecular docking: Evaluation of coumarin based derivatives against SARS-CoV-2 Chidambaram, Sathish Kumar Ali, Daoud Alarifi, Saud Radhakrishnan, Surendrakumar Akbar, Idhayadhulla J Infect Public Health Original Article BACKGROUND: The unique anthropological coronavirus which has been titled as SARS-CoV-2 was originally arisen in late 2019 in Wuhan, China affecting respiratory infection named as COVID-19. Coronavirus is disturbing human life in an exceptional method and has converted a public health global crisis. Natural products are ahead consideration due to the huge beneficial window and effective anti-inflammatory, immunomodulatory, antioxidant and antiviral possessions. Consequently, the present study was intended to display inhibition ability of natural products coumarins and their analogues against SARS coronavirus. METHODS: The present study, aims to forecast theoretical assembly for the protease of COVID-19 and to discover advance whether this protein may assist as a target for protease inhibitors such as psoralen, bergapten, imperatorin, heraclenin, heraclenol, saxalin, oxepeucedanin, angelicin, toddacoumaquinone, and aesculetin. The docking score of these natural coumarin analogues compared with standard Hydroxychloroquine. Whereas the 3D assembly of main protease of SARS coronavirus was forecast with SWISS MODEL web server, and molecular interaction studies amongst target protein and ligands were done with AutoDock Vina software. RESULTS: The study more exposed that all the inhibitors acquired with negative dock energy against the target protein. Molecular docking investigation displayed that natural coumarin analogue toddacoumaquinone displayed a remarkable inhibition ability with the binding energy of −7.8 kcal/mol than other compounds against main protease of SARS coronavirus in intricate with α-ketoamide (PDB ID: 5N5O). The synthetic coumarin analogue (1 m) also displayed the comparable inhibition ability with a binding energy of −7.1 kcal/mol against main protease of SARS coronavirus in intricate with α-ketoamide. Keeping the overhead results of ADME and toxicity, all tested compounds were recognized as drug-like nature, passing Lipinski’s “Rule of 5” with 0 violation except α-ketoamide passes Lipinski’s “Rule of 5” with 1 violation MW > 500. The projected constraints are within the assortment of recognized values. CONCLUSIONS: Based upon the results of the manifold sequence alliance, natural and synthetic coumarin binding sites were preserved. The present in silico examination thus, delivers structural awareness about the protease of COVID-19 and molecular relations with some of the recognised protease inhibitors. The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. 2020-11 2020-09-21 /pmc/articles/PMC7505582/ /pubmed/33008777 http://dx.doi.org/10.1016/j.jiph.2020.09.002 Text en © 2020 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Original Article
Chidambaram, Sathish Kumar
Ali, Daoud
Alarifi, Saud
Radhakrishnan, Surendrakumar
Akbar, Idhayadhulla
In silico molecular docking: Evaluation of coumarin based derivatives against SARS-CoV-2
title In silico molecular docking: Evaluation of coumarin based derivatives against SARS-CoV-2
title_full In silico molecular docking: Evaluation of coumarin based derivatives against SARS-CoV-2
title_fullStr In silico molecular docking: Evaluation of coumarin based derivatives against SARS-CoV-2
title_full_unstemmed In silico molecular docking: Evaluation of coumarin based derivatives against SARS-CoV-2
title_short In silico molecular docking: Evaluation of coumarin based derivatives against SARS-CoV-2
title_sort in silico molecular docking: evaluation of coumarin based derivatives against sars-cov-2
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505582/
https://www.ncbi.nlm.nih.gov/pubmed/33008777
http://dx.doi.org/10.1016/j.jiph.2020.09.002
work_keys_str_mv AT chidambaramsathishkumar insilicomoleculardockingevaluationofcoumarinbasedderivativesagainstsarscov2
AT alidaoud insilicomoleculardockingevaluationofcoumarinbasedderivativesagainstsarscov2
AT alarifisaud insilicomoleculardockingevaluationofcoumarinbasedderivativesagainstsarscov2
AT radhakrishnansurendrakumar insilicomoleculardockingevaluationofcoumarinbasedderivativesagainstsarscov2
AT akbaridhayadhulla insilicomoleculardockingevaluationofcoumarinbasedderivativesagainstsarscov2